More metastasis biomarkers such as TGM2 (Fig. 5D), GBP1 (Fig. 5E) and IGFBP7 (Fig. 5F) were checked too, and all of their expressions have a positive correlation with the expression in CAV1 in all different types of gliomas. Here, TGM2 is linked to central nervous system cancer.